SkinBioTherapeutics PLC

LSE:SBTX (UK)  
£ 0.17 (+4.48%) Dec 24
At Loss
P/B:
11.67
Market Cap:
£ 39.98M ($ 49.42M)
Enterprise V:
£ 39.99M ($ 49.44M)
Volume:
137.19K
Avg Vol (2M):
1.26M
Trade In:
Volume:
137.19K
At Loss
Avg Vol (2M):
1.26M

Business Description

Description
SkinBioTherapeutics PLC is a life science company focused on skin health. It is focused on the development of technology to protect, manage, and restore skin utilizing proteins found in the human microbiota. It is targeting three specific skin healthcare sectors; cosmetics, infection control, and eczema.
Name Current Vs Industry Vs History
Cash-To-Debt 0.98
Equity-to-Asset 0.57
Debt-to-Equity 0.28
Debt-to-EBITDA -0.3
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.29
Distress
Grey
Safe
Beneish M-Score 6.73
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 49.22
9-Day RSI 52.26
14-Day RSI 54.26
6-1 Month Momentum % 64.1
12-1 Month Momentum % 4.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.93
Quick Ratio 0.66
Cash Ratio 0.44
Days Inventory 127.68
Days Sales Outstanding 44.88
Days Payable 216.96

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -8.9
Shareholder Yield % -8.68

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 56.49
Operating Margin % -239.54
Net Margin % -237.88
FCF Margin % -241.85
ROE % -100.14
ROA % -71.78
ROIC % -119.35
ROC (Joel Greenblatt) % -1935.63
ROCE % -94.63

Financials (Next Earnings Date:2025-03-21 Est.)

LSE:SBTX's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

SkinBioTherapeutics PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £) 1.209
EPS (TTM) (£) -0.016
Beta 1.74
Volatility % 82.3
14-Day RSI 54.26
14-Day ATR (£) 0.011603
20-Day SMA (£) 0.1724
12-1 Month Momentum % 4.92
52-Week Range (£) 0.07 - 0.1975
Shares Outstanding (Mil) 228.44

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

SkinBioTherapeutics PLC Filings

Filing Date Document Date Form
No Filing Data

SkinBioTherapeutics PLC Stock Events

Financials Calendars
Event Date Price(£)
No Event Data

SkinBioTherapeutics PLC Frequently Asked Questions

What is SkinBioTherapeutics PLC(LSE:SBTX)'s stock price today?
The current price of LSE:SBTX is £0.17. The 52 week high of LSE:SBTX is £0.20 and 52 week low is £0.07.
When is next earnings date of SkinBioTherapeutics PLC(LSE:SBTX)?
The next earnings date of SkinBioTherapeutics PLC(LSE:SBTX) is 2025-03-21 Est..
Does SkinBioTherapeutics PLC(LSE:SBTX) pay dividends? If so, how much?
SkinBioTherapeutics PLC(LSE:SBTX) does not pay dividend.

Press Release

Subject Date
No Press Release